LCN2 and acute kidney injury: In contrast, thepresent study reports a real-life experience from heterogeneous patients where theresult of the NGAL was quickly available to the clinician within the same day, as weconsider this test characteristic essential for any acute diagnostic AKI biomarkerused in clinical practice.